Insights

Insights

筛选条件:

Filters

Glass.Mapper.Sc.Fields.Image?.Alt
Open Source Software & Compliance

Open Source in Healthcare and Life Sciences – Legal Framework and Compliance Requirements

Open source in healthcare requires robust compliance and security standards.

2026年7月9日
Briefing

作者 Jan Feuerhake, LL.M. (Melbourne) 以及 Gabriel Danyeli, LL.M. (Köln/Istanbul Bilgi)

点击此处了解更多
Glass.Mapper.Sc.Fields.Image?.Alt
汽车技术与出行

Labeling AI-Generated Content – Implementing the Transparency Requirements of the AI Regulation in the Automotive Sector

2026年7月8日
In-depth analysis

作者 Thomas Kahl 以及 Nils von Reith

点击此处了解更多
Glass.Mapper.Sc.Fields.Image?.Alt
UPC

The UPC’s first referral to the European Court of Justice: Cross-border preliminary injunctions against intermediaries and non-UPC defendants

2026年7月8日
In-depth analysis

作者

点击此处了解更多
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2

Hungarian supreme court on legal standing to challenge generic marketing authorisations

Case law – Hungarian Supreme Court (Kúria), precedent-setting judgment of 7 May 2026 – Kfv.37.810/2025/27 – On legal standing to challenge generic marketing authorisations

2026年7月2日
Briefing

作者 Fruzsina Kónya

8 / 9 观点

点击此处了解更多
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2

Case law – VfGH on the eImpfpass and central vaccination register

The Austrian Constitutional Court rejected challenges to the eImpfpass and central vaccination register on procedural grounds. The decision leaves the register in place, but highlights the role of data protection remedies in digital health infrastructure.

2026年7月2日
Briefing

作者 Christopher Bakier

6 / 9 观点

点击此处了解更多
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2

The new Product Liability Directive: three life sciences priorities before the 2026 deadline

The new EU Product Liability Directive applies to products placed on the market after 9 December 2026. Three changes call for decisions by life sciences companies now: software and AI as products, an eased burden of proof, and disclosure of internal evidence.

2026年7月2日
Briefing

作者 Bartosz Świdrak

3 / 9 观点

点击此处了解更多
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2

Update: AI-Enabled Medical Devices and IVDs Confirmed as “High-Risk”

Digital Omnibus Update. More time (up to August 2028) yet confirming that AI-enabled medical devices and IVDs stay subject to the AI Act.

2026年7月2日
Briefing

作者 Irina Rebin

4 / 9 观点

点击此处了解更多
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2

Poland’s new AI systems act: a regulator and practical tools

Poland’s new AI systems act builds the national framework for the EU AI Act. A new regulator is introduced, alongside two practical tools.

2026年7月2日
Briefing

作者 Bartosz Świdrak

9 / 9 观点

点击此处了解更多
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2

Medical Cannabis Platforms Breach Advertising Ban

Case law – German Federal Court of Justice (Bundesgerichtshof) – Online platforms brokering medical cannabis treatments breach the prohibition of public advertising under the German Healthcare Advertising Act

2026年7月2日
Briefing

作者 Irina Rebin

7 / 9 观点

点击此处了解更多
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2

France renews its simplified anti-gift conventions – what life sciences companies operating in France need to know

France enforces one of Europe's strictest anti-gift regimes, broadly prohibiting any benefit to healthcare professionals, in particular. Within this framework, simplified conventions offer a practical derogation — allowing companies to bundle hospitality declarations into a single filing. These conventions have just been renewed for another two years, with notable developments: COMIDENT (dental sector) joins as a signatory and a new two-month deadline applies for participant list submissions for certain types of convention.

2026年7月2日
Quick read

作者 Annabelle Lebaudy 以及 Marine Boullenger

5 / 9 观点

点击此处了解更多
Glass.Mapper.Sc.Fields.Image?.Alt
纠纷和调查

ARIHQ v. Santé Québec: Québec Superior Court set aside an arbitral award due to hallucinating AI

2026年7月2日
In-depth analysis

作者 Kerstin Bär, LL.M. (Bristol, UK) 以及 Donata Freiin von Enzberg, LL.M.

点击此处了解更多
Glass.Mapper.Sc.Fields.Image?.Alt
汽车技术与出行

Tightening of the “BIS Rules” for Connected Vehicle Technologies in the U.S. – Challenge for global Automotive Companies with China-Nexus

Restrictions on “Chinese” vehicle technologies in the U.S. – What’s it about?

2026年7月1日
In-depth analysis

作者 Thomas Kahl 以及 Dajin Lie

点击此处了解更多